BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8599723)

  • 1. Toxic neuropathies and their treatment.
    Ludolph AC; Spencer PS
    Baillieres Clin Neurol; 1995 Nov; 4(3):505-27. PubMed ID: 8599723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiological approach to peripheral neuropathy. Conventional nerve conduction studies and magnetic motor root stimulation].
    Ugawa Y
    Rinsho Shinkeigaku; 2004 Nov; 44(11):986-90. PubMed ID: 15651350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of peripheral neuropathies with neutrotrophic factors: animal models and clinical trials].
    Pradat PF
    Rev Neurol (Paris); 2003 Feb; 159(2):147-61. PubMed ID: 12660566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication and toxin-induced peripheral neuropathy.
    Pratt RW; Weimer LH
    Semin Neurol; 2005 Jun; 25(2):204-16. PubMed ID: 15937736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotrophic factors in the therapy of peripheral neuropathy.
    Apfel SC; Kessler JA
    Baillieres Clin Neurol; 1995 Nov; 4(3):593-606. PubMed ID: 8599726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic neuropathies.
    Grogan PM; Katz JS
    Neurol Clin; 2005 May; 23(2):377-96. PubMed ID: 15757790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diseases of the peripheral and visual nervous system during infection with human immunodeficiency virus].
    Casanova-Sotolongo P; Casanova-Carrillo P; Casanova-Carrillo C
    Rev Neurol; 2003 Sep 1-15; 37(5):481-5. PubMed ID: 14533099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth.
    Kirchmair R; Walter DH; Ii M; Rittig K; Tietz AB; Murayama T; Emanueli C; Silver M; Wecker A; Amant C; Schratzberger P; Yoon YS; Weber A; Panagiotou E; Rosen KM; Bahlmann FH; Adelman LS; Weinberg DH; Ropper AH; Isner JM; Losordo DW
    Circulation; 2005 May; 111(20):2662-70. PubMed ID: 15897348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies.
    Dati G; Quattrini A; Bernasconi L; Malaguti MC; Antonsson B; Nicoletti F; Alliod C; Di Marco R; Sagot Y; Vitte PA; Hiver A; Greco B; Roach A; Zaratin PF
    J Neuroimmunol; 2007 Oct; 190(1-2):8-17. PubMed ID: 17714795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatable peripheral neuropathies.
    Bradley WG
    Wien Klin Wochenschr Suppl; 1984; 147():14-21. PubMed ID: 6328776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic peripheral neuropathy.
    Smitt PS; Posner JB
    Baillieres Clin Neurol; 1995 Nov; 4(3):443-68. PubMed ID: 8599720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of the optacon as a screening device. A new technique for detecting sensory loss in individuals exposed to neurotoxins.
    Arezzo JC; Schaumburg HH
    J Occup Med; 1980 Jul; 22(7):461-4. PubMed ID: 6251189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies.
    Krarup-Hansen A; Helweg-Larsen S; Schmalbruch H; Rørth M; Krarup C
    Brain; 2007 Apr; 130(Pt 4):1076-88. PubMed ID: 17301082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline.
    Van Brakel WH; Nicholls PG; Das L; Barkataki P; Maddali P; Lockwood DN; Wilder-Smith E
    Lepr Rev; 2005 Dec; 76(4):277-95. PubMed ID: 16411508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve growth factor (NGF) may hold promise in treatment of peripheral neuropathy.
    AIDS Patient Care STDS; 1997 Jun; 11(3):197. PubMed ID: 11361801
    [No Abstract]   [Full Text] [Related]  

  • 17. Does neuropathy develop in animal models?
    Hounsom L; Tomlinson DR
    Clin Neurosci; 1997; 4(6):380-9. PubMed ID: 9358984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced neuropathy.
    Windebank AJ; Grisold W
    J Peripher Nerv Syst; 2008 Mar; 13(1):27-46. PubMed ID: 18346229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral neuropathy after bone marrow transplantation.
    Openshaw H
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):202-9. PubMed ID: 9360782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.